» Articles » PMID: 28493517

Clinicopathological Analysis of Primary Splenic Diffuse Large B-cell Lymphoma

Overview
Journal Br J Haematol
Specialty Hematology
Date 2017 May 12
PMID 28493517
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Splenic infiltration is often seen in diffuse large B-cell lymphoma (DLBCL). However, primary splenic DLBCL is rare and studies on its clinicopathological features are limited. We assessed 66 cases of primary splenic DLBCL and 309 control DLBCL, not otherwise specified. Hepatitis C virus antibody prevalence, B symptoms, poor performance status and CD5 positivity differed significantly between the primary splenic DLBCL and control DLBCL groups. Primary splenic DLBCL cases were classified histopathologically into two groups [white pulp pattern (n = 46), red pulp pattern (n = 20)]. Survival analysis showed no difference in overall survival between the primary splenic DLBCL and the control group, but the former had a more favourable progression-free survival. In the examination of primary splenic DLBCL, the white pulp pattern was statistically associated with a lower performance status (2-4), and a lower CD5 positivity than the red pulp pattern. In the survival analysis, the red pulp pattern demonstrated poorer overall survival. Multivariate analysis of overall survival in primary splenic DLBCL cases identified CD5 positivity as an indicator of poor prognosis. Classifying primary splenic DLBCL into white and red pulp patterns was useful in terms of clinicopathological features and overall survival.

Citing Articles

Unusual symptoms reveal a rare splenic lymphoma: a case report of PS-DLBCL with neck and shoulder pain as the initial presentation.

Hu S, Hao Y, Liu X, Liu H Front Oncol. 2025; 15:1449966.

PMID: 39968068 PMC: 11832353. DOI: 10.3389/fonc.2025.1449966.


Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database.

Yonghao O, Yongyang W, Siqing Y, Chengchao F, Lihua C, Xin L Indian J Hematol Blood Transfus. 2024; 40(2):220-230.

PMID: 38708154 PMC: 11065835. DOI: 10.1007/s12288-023-01706-6.


Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms.

Lekovic D, Ivanovic J, Terzic T, Perunicic Jovanovic M, Dencic Fekete M, Jovanovic J J Clin Med. 2024; 13(6).

PMID: 38542040 PMC: 10971563. DOI: 10.3390/jcm13061816.


Prognostic nomogram for primary splenic lymphoma: a SEER database-based study.

Chen F, Long H, Ding J, Ren J, Qu B, Cao P Am J Cancer Res. 2024; 13(12):5825-5845.

PMID: 38187057 PMC: 10767346.


Splenic Lymphomas: A Tertiary Care Center Experience and Review of Literature.

Jain S, Ramteke P, Gogia A, Mandal T, Aggarwal M, Dass J Indian J Hematol Blood Transfus. 2023; 39(3):402-412.

PMID: 37304493 PMC: 10247621. DOI: 10.1007/s12288-022-01621-2.